vTv Therapeutics (VTVT) Invested Capital: 2014-2025
Historic Invested Capital for vTv Therapeutics (VTVT) over the last 11 years, with Sep 2025 value amounting to $70.5 million.
- vTv Therapeutics' Invested Capital rose 293.81% to $70.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $70.5 million, marking a year-over-year increase of 293.81%. This contributed to the annual value of $14.3 million for FY2024, which is 157.95% up from last year.
- Latest data reveals that vTv Therapeutics reported Invested Capital of $70.5 million as of Q3 2025, which was up 2,454.06% from $2.8 million recorded in Q2 2025.
- In the past 5 years, vTv Therapeutics' Invested Capital registered a high of $70.5 million during Q3 2025, and its lowest value of -$56.3 million during Q1 2021.
- Its 3-year average for Invested Capital is $6.0 million, with a median of $8.9 million in 2025.
- As far as peak fluctuations go, vTv Therapeutics' Invested Capital plummeted by 196.54% in 2023, and later spiked by 293.81% in 2025.
- vTv Therapeutics' Invested Capital (Quarterly) stood at -$9.7 million in 2021, then dropped by 10.27% to -$10.7 million in 2022, then slumped by 129.80% to -$24.7 million in 2023, then surged by 157.95% to $14.3 million in 2024, then soared by 293.81% to $70.5 million in 2025.
- Its Invested Capital stands at $70.5 million for Q3 2025, versus $2.8 million for Q2 2025 and $8.9 million for Q1 2025.